NeuBase Therapeutics 10K 2014 Annual report | NBSE Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: abundant, Academy, acid, ad, adaptable, Alan, albumin, Alcon, allergy, anatomic, anatomical, approach, area, arm, asymptomatic, augment, automatically, Avalanche, baseline, biomarker, bound, breaker, breast, Bruch, burden, burst, CA, capacity, carboxyethylpyrrole, category, cell, CEP, certifying, chroidal, classic, coherence, Cold, comfort, complex, component, Composite, composition, confirmatory, contingent, contrast, conventional, coordination, correlated, CSHL, deficiency, depymed, deturgescence, Diego, disc, discontinue, discovered, disinterested, DME, docosahexaenoic, domain, drusen, economy, edema, efficient, elderly, electronically, elevated, emulsion, encountered, endpoint, epithelium, exemption, expansion, EyeCRO, fabrication, flexibility, fluid, forma, foveal, FovistaTM, frequency, furthest, gene, glaucoma, graph, greatest, grow, hoc, hydrogel, hyper, hyperreflective, Identification, immune, immunization, immunized, incorrect, indefinite, indirect, induction, inefficiency, inflammatory, influx, infrastructure, instance, Instruction, intercompany, Jason, jointly, lab, lactate, lesion, loading, meaningful, membrane, mice, micro, microparticle, milestone, monthly, motivated, mouse, MSA, nano, NBI, nonrecurring, obesity, occult, OCT, optimized, oral, organizational, outer, oxidation, parent, PDR, phagocytosed, phenotype, phosphatase, photoreceptor, pigment, platform, predefined, predictable, premium, PRN, proportion, proteomic, QID, quantitative, ranibizumab, RCMP, readout, Reallocation, regimen, regressed, regression, reliance, renewal, Rental, reorganization, resolution, restate, retention, RPE, run, San, Schmidt, screening, sensitivity, serum, session, shape, SHRM, Simplicity, SKS, Slakter, slowdown, solution, spectral, Spring, subfield, subgroup, subretinal, summary, template, thickening, today, tomography, topline, twelve, typically, undisclosed, unknown, unmet, unqualified, unsuccessful, upcoming, upfront, upregulation, variable, visit, week

Removed: absolute, accrual, AIGH, Andrew, assumed, billed, block, Bus, cancelled, Child, debenture, designing, direction, disorder, dispositive, ending, equivalent, expressing, father, Finally, financed, infusion, investigate, investigational, issuing, Limpert, moving, nearest, nutritional, opened, operated, opposed, Orphan, outlay, ovarian, owner, Packer, personally, promise, purpose, reevaluate, reformulated, refractory, released, resigned, resistant, retired, Rounded, salary, shareholder, shifted, solid, surviving, undervalued, Van, VP, Wagoner, wasting, worth

	1.	Ohr Opco, Inc. (incorporated in Delaware)

	2.	Ohr Pharma, LLC (organized in Delaware)

NeuBase Therapeutics (NBSE) 10-K2014 FY Annual report

Content analysis